Press release content from PR Newswire. The AP news staff was not involved in its creation.
Expanding the Limits of IV Site Monitoring: ivWatch Secures Four New Patents Globally
January 21, 2021 GMT
NEWPORT NEWS, Va., Jan. 21, 2021 /PRNewswire/ ivWatch, LLC, inventor of the first and only continuous IV infiltration detection technology, today announced four new patent grants in Australia, Japan and Europe. The company’s robust patent portfolio has expanded to 39 patents around the world protecting its core technologies. The technologies work as a system to notify clinicians in real time of an IV infiltration or extravasation, which helps reduce patient harm and improve outcomes in IV therapy.